ArticleVirology journal2025
Prevalence characteristics of human papillomavirus among women in Henan Province of China.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An epidemiological survey of HPV infection among women in Southern Hebei, China.Virology journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study is to analyze the prevalence and genotype distribution of HPV among the female populations in Henan Province, which can provide an evidence for the local governments to make develop strategies for cervical cancer prevention and vaccination.
methodsThe study was designed to analyze the results of cervical swab HPV test results from female patients who visited the First Affiliated Hospital of Zhengzhou University from January 2020 to May 2023. The collected cervical specimens were processed using specialized nucleic acid extraction reagents to obtain purified nucleic acid extracts. Genotype identification was then performed via real-time fluorescence PCR technology with two commercial detection kits. The assay detects 23 HPV genotypes (17 high-risk types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82; and 6 low-risk types: 6, 11, 42, 43, 44, 81). The HPV prevalence was calculated using GraphPad Prism 8.0.
resultsThe overall HPV prevalence was 21.31% (12,950/60,765) among the 60,765 female patients, of which the single, double, and multiple HPV infections accounted for 14.81% (9,001/60,765), 4.25% (2,584/60,765), and 2.25% (1,365/60,765) of the total cases. 17.82% (10,836/60,765) of the total samples were infected with high-risk HPV (HR-HPV), accounting for 83.67% (10,836/12,950) of the HPV positive women. The most common infection pattern is HPV single infection, accounting for 69.51% of the positive women. The top four most commonly detected types were HPV-52 (4.30% 2,612/60,765), HPV-58 (2.81% 1,710/60,765), HPV-16 (2.81% 1,709/60,765), and HPV-53 (2.25% 1,367/60,765). The positive rate of HPV among different age groups was statistically significant (p<0.05).
conclusionThis study provides baseline data on the epidemiological characteristics of HPV. The prevalence of HPV among women in Henan Province is high. The highest prevalence is among women less than 20 years. The predominant genotypes identified were HPV 52, 58, 16, and 53. This genotype distribution suggests that the Gardasil 9 vaccine, which covers HPV 52, 58, and 16, could potentially address a significant proportion of high-risk HPV infections in this population. The high prevalence of HPV 53, a genotype not targeted by current vaccines, warrants further investigation into its oncogenic role and epidemiological significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.